−0.047 PLN
−2.30 M PLN
1.22 M PLN
About Medicofarma Biotech Spolka Akcyjna
Sector
Industry
CEO
Robert Kilczewski Cezary
Website
Headquarters
Warsaw
Founded
2001
ISIN
PLINBOK00010
FIGI
BBG000LB1LL0
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. It involves in the research and development works in collaboration with pharmaceutical and cosmetic manufacturing plants, as well as research units. The company was founded by Mariusz Dabrowski in 2001 and is headquartered in Warsaw, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDB is 0.920 PLN — it has increased by 148.65% in the past 24 hours. Watch Medicofarma Biotech Spolka Akcyjna stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange Medicofarma Biotech Spolka Akcyjna stocks are traded under the ticker MDB.
MDB stock has risen by 220.56% compared to the previous week, the month change is a 199.67% rise, over the last year Medicofarma Biotech Spolka Akcyjna has showed a 79.69% increase.
MDB stock is 81.85% volatile and has beta coefficient of −0.36. Track Medicofarma Biotech Spolka Akcyjna stock price on the chart and check out the list of the most volatile stocks — is Medicofarma Biotech Spolka Akcyjna there?
Today Medicofarma Biotech Spolka Akcyjna has the market capitalization of 25.15 M, it has decreased by −0.33% over the last week.
Yes, you can track Medicofarma Biotech Spolka Akcyjna financials in yearly and quarterly reports right on TradingView.
MDB net income for the last quarter is −655.72 K PLN, while the quarter before that showed −725.20 K PLN of net income which accounts for 9.58% change. Track more Medicofarma Biotech Spolka Akcyjna financial stats to get the full picture.
No, MDB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 11, 2025, the company has 24 employees. See our rating of the largest employees — is Medicofarma Biotech Spolka Akcyjna on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medicofarma Biotech Spolka Akcyjna EBITDA is −1.45 M PLN, and current EBITDA margin is −44.35%. See more stats in Medicofarma Biotech Spolka Akcyjna financial statements.
Like other stocks, MDB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medicofarma Biotech Spolka Akcyjna stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medicofarma Biotech Spolka Akcyjna technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medicofarma Biotech Spolka Akcyjna stock shows the buy signal. See more of Medicofarma Biotech Spolka Akcyjna technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.